CVS Health Stops Administering JNJ COVID-19 Shot In Several Locations

 

• Drugstore chain CVS Health Corporation CVS 2.39% is no longer offering Johnson & Johnson's JNJ 0.27% COVID-19 vaccine in many of its retail locations, the company told CNBC on Wednesday.
• According to CVS spokesman Mike DeAngelis, retail locations continue to offer either the Moderna Inc MRNA 1.14% or Pfizer Inc PFE 0.54% - BioNTech SE BNTX 2.3% vaccine.
• DeAngelis said the change was implemented "several weeks ago and helps us manage our vaccine supply across the chain, both in our pharmacies and clinics."
• He added that the Johnson & Johnson vaccine is still offered at almost 1,000 of its MinuteClinic locations in 25 states and Washington, D.C. 
• The Johnson & Johnson vaccine was touted as a potential game-changer when it was initially authorized, being a single-dose shot, and can be stored at normal refrigerator temperatures.
• But the vaccine has been beset by production issues and concerns about its effectiveness against the delta variant. 

https://www.benzinga.com/general/biotech/21/08/22356102/cvs-health-stops-administration-of-jnj-covid-19-shot-in-several-locations-cnbc